Skip to main content
logo
Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
21.38
-0.27 (-1.25%)
Feb 5, 2026, 2:18 PM EST - Market open

Roivant Sciences Revenue

Roivant Sciences had revenue of $1.57M in the quarter ending September 30, 2025, a decrease of -64.89%. This brings the company's revenue in the last twelve months to $20.33M, down -45.13% year-over-year. In the fiscal year ending March 31, 2025, Roivant Sciences had annual revenue of $29.05M, down -11.19%.

Revenue (ttm)
$20.33M
Revenue Growth
-45.13%
P/S Ratio
731.28
Revenue / Employee
$27,105
Employees
750
Market Cap
14.87B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202529.05M-3.66M-11.19%
Mar 31, 202432.71M1.18M3.75%
Mar 31, 202331.53M-23.76M-42.97%
Mar 31, 202255.29M31.49M132.34%
Mar 31, 202123.80M-43.89M-64.85%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Incyte4.81B
Genmab3.85B
BioMarin Pharmaceutical3.09B
Exelixis2.29B
Moderna2.23B
Ionis Pharmaceuticals966.96M
Ascendis Pharma758.59M
BridgeBio Pharma353.78M
Revenue Rankings

ROIV News

More News